Home Stock Market Vaccine deployment of Moderna COVID-19 begins in the UK, replacing AstraZeneca under...

Vaccine deployment of Moderna COVID-19 begins in the UK, replacing AstraZeneca under 30 years old


Moderna
MRNA,
-1.08%

0A45,
-2.63%

The COVID-19 vaccine will begin use in the UK from Tuesday, providing an alternative to AstraZeneca
AZN,
-1.04%

AZN,
-0.98%

vaccine for people under 30 years old.

UK Vaccine Advisory Committee, Joint Commission on Immunization and Immunization (JCVI), last week suggestions that people 18 to 29 years old receive another vaccine, following reports of extremely rare blood clots in a small number of people receiving the AstraZeneca shot.

Both the European and UK pharmaceutical regulators say that the benefits of the AstraZeneca vaccine outweigh the risks to “the vast majority” of everyone, and no age limit is recommended for the shot.

Shares of AstraZeneca traded 0.78% lower in London on Tuesday morning.

The launch of the Moderna vaccine will help accelerate the UK’s vaccination program, which has already surpassed progress after meeting its goal on Monday to deliver the first COVID-19 vaccine to all. over 50 years old on April 15.

Biotech Moderna says it will produce at least 700 million doses of the vaccine by 2021, including from factories in Europe and the US. The UK has secured 17 million doses of this vaccine.

Read: Europe’s vaccine disaster continues to happen as Spain and Italy stop using AstraZeneca injections for people under the age of 60.

Nearly 40 million vaccines are currently used for more 32 million people in the UK, the government said in a statement late on Monday. The two main vaccines offered are the one produced by the Anglo-Swedish pharmaceutical company AstraZeneca in cooperation with the University of Oxford and the one produced by the German biotechnology company BioNTech.
BNTX,
-0.51%

and US pharmaceutical company Pfizer
PFE,
+ 1.01%
.

This includes more than seven million second doses – with a record number of 475,230 injected on Saturday – leaving the government on track to deliver the first vaccine to all adults by July 31.

JCVI is expected to soon release its final advice on how the government should vaccinate people under the age of 50, paving the way for the next phase of its immunization program, which is expected to begin this week. , the government said.

Read: The UK is set to partially reopen upon easy locking restrictions

This news will create a significant impetus for Prime Minister Boris Johnson’s plan to get the country out of a third stalemate by opening parts of the economy. On Mondays, shops, hair salons and outdoor receptions reopened in the UK and the holiday abroad can continue from May 17, subject to the success of immunization program.

Read: The CDC offers travel advice to Americans who have been vaccinated – but stops at saying that you can get on a plane.

Last week, eight airline bosses – including the IAG heads
IAG,
+ 1.14%

-owned British Airways, Virgin Atlantic, Ryanair
RYAAY,
-3.12%

and easyJet
EZJ,
+ 2.16%

– wrote to Johnson, calling for travel between the US and UK starting May 17th. “Economic recovery is not possible without aviation and we are confident that we have the tools to safely and effectively restart air travel in May, ”they wrote in a letter published in Sun newspapers.

When the unnecessary foreign travel ban was lifted, the government said it would be replaced with a risk-based measure, three-storey traffic light system to categorize countries for international travel to and from the UK.

Read: Britons don’t want to spend when pubs, shops, gyms and hair salons reopen in the UK.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments